Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-01-13 @ 5:17 PM
Study NCT ID:
NCT00644020
Status:
UNKNOWN
Last Update Posted:
2008-03-26
First Post:
2008-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients
Sponsor:
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-12
Start Date Type:
None
Primary Completion Date:
2008-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2008-08
Completion Date Type:
ESTIMATED
First Submit Date:
2008-03-23
First Submit QC Date:
None
Study First Post Date:
2008-03-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-03-25
Last Update Post Date:
2008-03-26
Last Update Post Date Type:
ESTIMATED